510(k) Report

De Novo · Granted

Granted

TrueTear Intranasal Tear Neurostimulator

DEN170086De NovoGranted May 17, 2018206-day reviewClass II21 CFR 886.5310

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Allergan · QBR Intranasal Electrostimulation Device For Dry Eye Symptoms

Granted on May 17, 2018 as a new device type through De Novo after a 206-day review. 1 later device descends from it.

Decided
May 17, 2018
Review
206 days
Class
Class II
Product code
QBR
Recalls
None

1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2020: 1 descendant cleared201620182020202220242026
  1. This deviceDEN170086 TrueTear Intranasal Tear NeurostimulatorAllergan · 2018
  2. Descendant · cites it directly · 0 of its ownK193589 TrueTear Intranasal Tear NeurostimulatorAllergan · 2020

Most influential descendants

Showing 1 of 1 · See all
  • K193589TrueTear Intranasal Tear NeurostimulatorAllergan · 2020 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)DEN170086TrueTear Intranasal Tear NeurostimulatorAllergan2018—
+1K193589TrueTear Intranasal Tear NeurostimulatorAllergan2020—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202010
FIG. 1 — Lineage of DEN170086, 2018–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA De Novo database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QBR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QBR device

  1. #1 K193589 TrueTear Intranasal Tear Neurostimulatorscore -0.1 · 1 generation · no Class I recall
Get a 510(k) Report

Does it have a predicate?

De Novo decisions do not claim a predicate device.

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K193589TrueTear Intranasal Tear NeurostimulatorAllergan20200

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K193589 (Allergan, 2020) has gone furthest, with 0 descendants of its own.

How does its category compare?

All QBR devices

QBR Intranasal Electrostimulation Device For Dry Eye Symptoms: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · QBR

1in 2020

2018: 12020: 1
2007high 1 (2018) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QBR

Too few QBR 510(k)s in any year since 2007 to give a median.

Recalls per year · QBR

No recall names QBR since 2007.

Adverse event reports per year · QBR

No MAUDE report names QBR since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20181—00
20190—00
20201—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The TrueTear Intranasal Tear Neurostimulator provides a temporary increase in tear production during neurostimulation to improve dry eye symptoms in adult patients with severe dry eye symptoms.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “DEN170086: TrueTear Intranasal Tear Neurostimulator.” Lineage record from FDA De Novo data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/DEN170086

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026